Progress in examining cost-effectiveness of AI in diabetic retinopathy screening
- PMID: 33328051
- DOI: 10.1016/S2589-7500(20)30077-7
Progress in examining cost-effectiveness of AI in diabetic retinopathy screening
Comment on
-
Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.Lancet Digit Health. 2020 May;2(5):e240-e249. doi: 10.1016/S2589-7500(20)30060-1. Epub 2020 Apr 23. Lancet Digit Health. 2020. PMID: 33328056
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
